Human Liver Model Global Market Report 2024 - By Growth, Size, Share, Demand, Outlook By 2033

The human liver model market size has grown rapidly in recent years. It will grow from $2.07 billion in 2023 to $2.33 billion in 2024 at a compound annual growth rate (CAGR) of 12.7%. The growth in the historic period can be attributed to drug development needs, advancements in biotechnology, animal testing alternatives, rising liver diseases, regulatory demands.

The human liver model market size is expected to see rapid growth in the next few years. It will grow to $3.79 billion in 2028 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to ai and machine learning integration, patient-derived liver models, bioengineering breakthroughs, drug safety and toxicity testing requirements, virtual clinical trials. Major trends in the forecast period include multi-organ models integration, 3d bioprinting innovations, high-throughput screening capability, enhanced vascularization and blood flow, ethical and regulatory compliance.

Market Overview -
The human liver model refers to the model of dual-lobed liver of humans that is primarily in charge of filtering blood from the digestive tract. It is used to show and evaluate the toxic effects of drug candidates on the liver.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=12244&type=smp

Rising Incidence Of Liver Disease Drives Growth In The Human Liver Model Market
The rising cases of liver disease are expected to propel the growth of the human liver model market going forward. Liver disease refers to any disorder of the liver that can stop the liver from working or prevent it from functioning well. The use of human liver models is an emerging area of research that has the potential to improve the understanding of liver diseases and drug development. Hence, the rising cases of liver diseases are propelling the growth of the human liver model market. For instance, in September 2022, according to Caner Australia, an Australia-based government cancer agency, around 2,905 new cases of liver cancer were diagnosed in Australia in 2022 (2,113 males and 792 females). Further, the risk of developing liver cancer by age 85 is predicted to be 1 in 103 (or 0.97%) in 2022, 1 in 70, or 1.4%, for men, and 1 in 195, or 0.51%, for women. Therefore, the rising cases of liver disease are propelling the human liver model market.

Competitive Landscape -
Major companies operating in the human liver model market report are Corning Incorporated, EISCO Scientific LLC, BioIVT LLC, Cyprotex plc, Emulate Inc., Cellink AB, Strand Life Sciences Pvt Ltd., Nortis Inc., InSphero AG, CN Bio Innovations Ltd., TissUse GmbH, Ascendance Biotechnology Inc., HemoShear Therapeutics Inc., Cyfuse Biomedical KK, Cyfuse Biomedical, MIMETAS BV, Bio Innovations, Biopredic International Sarl, ZenBio, Hurel Corporation, Regenovo, Pandorum, Organovo Holdings Inc., BICO Group, Hepregen Corporation, Kirkstall Ltd., HepaLife Technologies Inc., Cellaïon SA.

Product Innovation In The Human Liver Model Market
Product innovation has emerged as a key trend gaining popularity in the human liver model market. Major companies operating in the human liver model market are concentrating on creating innovative products to strengthen their position in the market. For instance, in April 2023, LifeNet Health Life Sciences, a US-based human cell and tissue-based solution provider launched TruVivo, a ground-breaking liver system made entirely of human cells that will aid in the crucial research and development of new drugs and compounds. This innovative 2D+ solution combines the robust data that goes with 3D models with the flexibility and simplicity of a 2D model.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/human-liver-model-global-market-report

Key Segments -
The human liver model market covered in this report is segmented -
1) By Product: Liver Organoids, Liver-On-A-Chip, 2D Models, Animal Models, 3D Bioprinting
2) By Application: Educational, Drug Discovery, Other Applications
3) By End Users: Research Institutes, Pharmaceutical Companies, Other End Users

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model"

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.